Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7058 Combined With Anti-tumor Drugs in Solid Tumors
NCT07032077Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Jul 2025
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7058 in solid tumor, sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Jul 2025; status: recruiting.
02
Drugs
HRS-7058
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07032077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07032077.